Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis
Clinical trial NCT02727907 · COMPLETED
Trial details
- NCT number
- NCT02727907
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-12
- Primary completion
- 2016-11-21
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.